Evidence map›Paper›PMID 36315224›Full record

ArticleJMIR research protocols2022

Incentives and Reminders to Improve Long-term Medication Adherence (INMIND): Protocol for a Pilot Randomized Controlled Trial.

Chad Stecher, Ishita Ghai, Lillian Lunkuse, Peter Wabukala, Mary Odiit, Agnes Nakanwagi, Sebastian Linnemayr

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05131165 (INcentives and ReMINDers to Improve Long-term Medication Adherence), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05131165 nacompletednot on this map

INcentives and ReMINDers to Improve Long-term Medication Adherence

TypeinterventionalSponsorRANDRan2021 to 2023Enrolled166ConditionsHIV/AIDSArmsDaily Text Messages, Incentivization based on timely ART adherence
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Chad StecherCollege of Health Solutions, Arizona State University, Phoenix, AZ, United States.ORCID https://orcid.org/0000-0003-2218-3306
Ishita GhaiPardee RAND Graduate School, Santa Monica, CA, United States.ORCID https://orcid.org/0000-0003-3052-721X
Lillian LunkuseMildmay Uganda, Kampala, Uganda.ORCID https://orcid.org/0000-0001-5485-4966
Peter WabukalaMildmay Uganda, Kampala, Uganda.ORCID https://orcid.org/0000-0001-7171-4180
Mary OdiitMildmay Uganda, Kampala, Uganda.ORCID https://orcid.org/0000-0002-0611-5867
Agnes NakanwagiMildmay Uganda, Kampala, Uganda.ORCID https://orcid.org/0000-0002-6179-7880
Sebastian LinnemayrRAND Corporation, Santa Monica, CA, United States.ORCID https://orcid.org/0000-0002-6945-5279
Mildmay Uganda · UGArizona State University · USRAND Corporation · USRAND School of Public Policy · US

Funding

Incentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)R34MH122331 · NIMH · RAND CORPORATION · PI LINNEMAYR, SEBASTIAN · 2020 to 2022
$695k
NIMH NIH HHS R34 MH122331
6 · The paper itself

Abstract

backgroundNonadherence to antiretroviral therapy (ART) among people living with HIV is a crucial barrier to attaining viral suppression globally. Existing behavioral interventions have successfully increased ART adherence, but typically show only short-term impact that dissipates after the interventions are withdrawn.

objectiveThis study aims to test the feasibility, acceptability, and preliminary efficacy of a novel intervention that uses SMS text messages and conditional incentives to support ART initiators in establishing pill-taking habits.

methodsA sample of 150 participants aged ≥18 years who have initiated ART in the preceding 3 months will be recruited from Mildmay Uganda in Kampala, Uganda. All (150/150, 100%) participants will be educated on the anchoring strategy and will choose an existing routine to pair with their daily ART adherence from a set of 3 suggested routines: getting dressed in the morning, eating breakfast, or eating dinner. Then, participants will be randomized to receive either usual care (control group: 50/150, 33.3%) or 1 of the 2 interventions delivered over 3 months: daily SMS text message reminders to follow their chosen anchoring plan (messages group; treatment group 1: 50/150, 33.3%) or daily SMS text messages and incentives conditional on taking their ART medication around the time of their chosen anchor (incentives group; treatment group 2: 50/150, 33.3%). Long-term ART adherence will be evaluated for 6 months after the intervention, and survey assessments will be conducted at baseline, 3 months, and 9 months. Outcomes include feasibility and acceptability measures and intervention efficacy outcomes defined by electronically measured mean medication adherence during the intervention and during the 6 months after the intervention, along with a measure of routine ART adherence based on taking medications around the time of participants' anchor during the intervention and during the 6 months after intervention.

resultsAs of February 18, 2022, recruitment was completed. A total of 150 participants were recruited, and data collection is expected to end in December of 2022. Final results are expected to be submitted for publication by April 2023.

conclusionsThis study is the first to use behavioral economics-based interventions in combination with the anchoring strategy to improve long-term ART adherence among treatment initiators. We hypothesize that the combination of SMS text message reminders and incentives will increase participants' use of their anchoring strategy, and thus medication adherence will be better maintained after the intervention ends in our intervention groups relative to the control group that uses only the anchoring strategy. Results of this pilot study will help to refine this combined intervention approach for testing at scale and broaden our understanding of the habit formation process.

trial registrationClinicalTrials.gov NCT05131165; https://clinicaltrials.gov/ct2/show/NCT05131165. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/42216.

Indexed as

antiretroviral therapybehavioral economicshabit formationHIVmedication adherenceroutines

Identifiers

PMID36315224
PMCPMC9664328
OpenAlexW4297186570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.